Haran Schlamm, MD

HTS Pharma

Disclosure(s): Amplyx: Advisor/Consultant; Basilea: Advisor/Consultant; Pfizer: Advisor/Consultant

Poster(s):

• (P-1192) Fosmanogepix Expanded Access Experience in Patients With Invasive Aspergillosis
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1351) Fosmanogepix Expanded Access Experience in Patients With Fusarium Infections
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET